Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/nvidia-nvda-stock-hits-new-low-for-the-year/